Learn More
Genscript Corporation CD164 hFc Chimera Human
Supplier: Genscript Corporation Z04164500
CD164 was found to play a role in many malignant diseases CD164 was associated with clinical and pathological features of patients High level of CD164 was related to the distant metastasis and vascular invasion of bladder cancer patients CD164 was associated with the poor clinical outcomes of BC patients Silencing of CD164 could inhibit the progression of tumors in vivo and in vitro which may become an effective target in the treatment of bladder cancer
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.